Lilly and AstraZeneca Expand Immuno-Oncology Research Collaboration with New Combinations
Go back to Lilly and AstraZeneca Expand Immuno-Oncology Research Collaboration with New Combinations| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,691,379 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,691,379 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1273.46 -33.23 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1306.69 | 52 Week High | $88.16 | |||
| Open | $1304.15 | 52 Week Low | $67.88 | |||
| Day High | $1307.92 | P/E | 294.78 | |||
| Day Low | $1257.62 | EPS | $4.32 | |||
| Volume | 2,277,291 | |||||



